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ABSTRACT 
Objective: Hepatic cancer is known as primary liver cancer and hepatocellular carcinoma (HCC). Newly silver nanoparticles gained importance due 
to its advantages and multiple potential such as molecular imaging agent, antimicrobial, wound healing, anti-inflammatory and anticancer activity. 
The current study deals to assess therapeutic property silver nanoparticles (AgNPs) against diethylnitrosamine (DENA), and carbon tetrachloride 
(CCL4) induced hepatic cancer. 
Methods: Thirty male albino rats (200-250g) were distributed into four groups and hepatic cancer was induced with a single intraperitoneal dose 
of 200 mg/kg body weight of DENA. Two weeks later, animals received subcutaneous injections of CCl4 once a week in a dose of 3 ml/kg body 
weight for 6weeks. Serum biomarkers, antioxidants enzymes, inflammatory markers were evaluated to find the anti-proliferative potential of silver 
nanoparticles. Histological evaluation and microscopic reports were also done to document the results of the current work. 
Results: AgNPs significantly recover the serum marker enzymes of hepatic parameter AST, ALT, ALP, and total bilirubin and also decreased the levels of NO, 
IL-6 and TNF-α. Histopathological features also exhibited recovery of a hepatic architecture in cancer-induced rats. Moreover, the immunohistochemical 
investigation demonstrated that the levels of PCNA, and Caspase-3, which are hepatocarcinogenic markers, were significantly improved by AgNPs.  
Conclusion: These results concluded that AgNPs showed promising curing effects on hepatocellular ailments. 
Keywords: Hepatocellular carcinoma (HCC), Diethylnitrosoamine (DENA), Carbon tetrachloride (CCL4), Silver nanoparticles (AgNPs), Apoptosis, 
Interleukin-6(IL-6) 
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INTRODUCTION 
The liver is the largest solid organ and one of the most vital organs that 
functions as xenobiotic and drug, energy, protein and amino acid 
metabolism, storage of glucose in the form of glycogen, storage of 
vitamins, and regulation of hormonal functions. Ozougwu stated that a 
total loss of liver function might lead to death within minutes, 
indicating the liver‘s great importance. Hepatocellular carcinoma 
(HCC) is a life-threatening neoplasm that originated from hepatocytes, 
representing approximately 80% of liver cancer and 3rd most common 
cancer-related death [1]. HCC is an extremely vascularized and 
malignant tumor that is responsible for poor survival and rapid 
recurrence in patients [2]. Human cancers are related to chronic 
inflammation caused by chemical, biological and, physical factors. The 
effect of inflammation-fibrosis-carcinoma axis acts as a bridge from 
inflammation to cancer, and therefore promotes inflamed liver 
development to fibrosis/cirrhosis and HCC [3]. Upon exposure to risk 
factors like alcohol, viruses, parasites and, toxic substances, the hepatic 
injury resulted in the degeneration and inflammation, leading to 
chronic liver diseases, which may further progress to different stages 
of fibrosis, cirrhosis, and HCC. HCC is the final stage of this process [3].  
Drug-induced liver cancer in rats is an important tool to study 
primary HCC such as Ethanol, carbon tetrachloride (CCl4), afatoxin, 
nitrosamines, amino azo dyes, aromatic amine and so on all are used 
to induce HCC in animal models. Diethylnitrosamine (DENA) is 
amongst the most essential natural carcinogenic agents, which is 
known to cause changes in the enzymes required in DNA repair 
replication and is regularly utilized as a cancer-causing agent to 
prompt liver carcinogenesis in mouse models [4].  
DENA is a well-known potent hepatocarcinogenic agent present in 
tobacco smoke, water, cured and fried meals, cheddar cheese, 
agricultural chemicals, cosmetics, and pharmaceutical products [5]. 
In experimental induction of HCC in animal models, we use the two-
stage application of chemicals for the initiation and promotion of 
hepatocellular tumors. The initiator in this protocol is a single 
injection of a dose of DENA. Two weeks later, animals received 
subcutaneous injections of CCl4 for 6 w to promote the carcinogenic 
effect of DENA. Uehara et al. reported that DENA/CCl4 mouse model 
differs from animal models utilizing either agent alone in that the 
resultant chronic liver fibrosis is accompanied by a dramatic 
increase in the liver tumor incidence, with 100% of the mice in the 
co-treatment group developing liver tumors by 5 mo of age.  
The HCC is an extremely vascularized tumor, in which angiogenesis 
has a critical role in the progression, metastasis, and frequency [6]. 
One of the angiogenic stimulating factors is oxidative 
stress/inflammatory cascade. It enhances the vascular permeability 
and chemokine-mediated enrolment of leukocytes and platelets with 
major angiogenic cytokines and growth factors release. The most 
important of these are nitric oxide (NO), vascular endothelial growth 
factor (VEGF), platelet-derived growth factor (PDGF), interleukin-4 
(IL-4), interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-α) 
[7]. Furthermore, dysregulated apoptosis has a crucial role in HCC 
tumorigenesis and acquired resistance to chemotherapy. 
Nanotechnology, a concept in the field of science and technology in 
recent years, has also been likely to grow based on their demand, 
like other technologies. Nanoparticles are usually a cluster of atoms 
ranging between 1-100 nm in size and they exhibit new properties 
based on their size, distribution and morphology [8]. Many materials 
are synthesized in nanosize for various applications, including 
medicine, mechanical, biomedical, and electronics. Though the 
biological method is commonly adopted for the creation of silver 
nanoparticles, the use of plant extracts is widely spread studied due 
to its advantages over others [9]. 
Among the nanoparticles, nanosilver has potential applications in the 
field of biomedicine since silver has a disinfecting effect and has found 
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uses in traditional medicines for a long time [10]. The AgNPs prevents 
VEGF-stimulated angiogenesis as well as cellular proliferation and 
migration induced by activated phosphatidylinositol-3-kinases/Protein 
kinase B (PI3K/Akt) signaling pathways [11, 12]. Moreover, different 
cytotoxic effects and reduction in cellular viabilities ending in anti-
proliferative effects through oxidative stress-apoptotic pathways were 
recognized by using AgNPs both in various cancer cell lines, including 
human hepatocellular carcinoma cell line HepG2 [13] and other in vivo 
cancer models regardless HCC models. 
Among different plants, the seeds of Nigella sativa had shown to 
exhibit various medicinal properties such as anti-diabetic [14], anti-
allergic [15], anti-inflammatory, antibacterial, antioxidant and 
anticancer activity [16]. The aim of the present investigation was the 
therapeutic effect of synthesizing silver nanoparticles using seeds of 
Nigella sativa as a reducing agent on DENA/CCl4-induced liver 
cancer in animal models through contemplating the biochemical 
parameters, immune histology and histopathology of tissues. 
MATERIALS AND METHODS  
Drugs and chemicals 
Diethylnitrosamine (N-nitrosodiethylamine; DENA; purity, 99.0%) 
and CCl4were purchased from Sigma-Aldrich Company, St. Louis., 
USA. DENA was diluted in saline (0.9% NaCl) while CCl4 was diluted 
in corn oil. AgNPs were synthesized using a green biosynthesis 
method by reducing the AgNO3 solution with aqueous extract of 
Nigella sativa according to [9]. 
Preparation of aqueous silver nitrate  
Silver nitrate solution (1 M) was prepared and stored in an amber-
colored bottle. 
Preparation of extract from seeds of nigella sativa  
The seeds of Nigella sativa were washed several times with deionized 
water. The extract used for the synthesis of silver nanoparticles was 
prepared by adding 20 g to 100 ml of distilled water. The suspension 
was homogenized and centrifuged, after that the supernatant was 
collected and the extract obtained was filtered through Whatman No. 1 
filter paper, finally, the filtrate was stored at 4 ᵒC  
Synthesis of silver nanoparticles  
Five different aliquots of the seed extracts (1-5 ml) were taken 
separately and 10 ml of 1 mmol silver nitrate solution was added 
with constant stirring and exposed to sunlight radiation. The color 
change of the solution was checked periodically; from yellow to dark 
brown indicated that the silver nanoparticles were synthesized. 
Induction of hepatocellular carcinoma 
Induction of HCC was through two consecutive stages: initiation and 
promotion by DENA and CCl4; respectively [17]. For initiation, DENA 
was injected i. p to each rat in a single dose of 200 mg/kg b. wt [18]. 
Two weeks later, animals received subcutaneous injections of CCl4 
(CCl4/olive oil; 1:1; 1 ml/kg) once a week in a dose of 3 ml/kg b. wt 
for 6 w to promote the carcinogenic effect of DENA [19]. 
30 adult male albino rats were employed in the present study. They 
were obtained from the Serum and Antigen Laboratories at Helwan. 
Their weight ranged between (200-250g). The experimental 
protocols were carried out corresponding to the guidelines for the 
animal experiment, which was approved by the Ethical Committee of 
the Medical Research Center. Giza. Egypt (registration number: 
13/165). Animals were allowed a one-week pre-experimentation 
period to adapt to laboratory conditions in order to avoid any 
complications along the course of the experiment. After one week 
acclimatization period, the rats divided into four groups; group I (5 
rats): normal control, group II (5 rats): solvent control group: Rats 
were injected i. p. with 1 of ml olive oil for 6 w, group III (10 rats): 
DENA/CCl4-treated group (HCC group): Rats received a single dose 
of DENA (200 mg/kg b. wt i. p). Two weeks later, animals received 
subcutaneous injections of CCl4 once a week in a dose of 3 ml/kg b. 
wt for 6 w. Group IV (10 rats): DENA/CCl4/AgNPs-treated group: 
After induction of HCC, AgNPs were daily given by oral gavage in a 
dose of 300 mg/kg b. wt from the start of the 9th week for 21 d. 
Blood and liver sampling 
At the end of the experiment, blood samples for biochemical and 
biological analyses were collected from the heart in clean, dry test 
tubes. The collected blood was left to coagulate. After centrifugation 
at 4000 r. p. m. for 10 min (4 °C), sera were separated and used for 
determination of aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), alkaline phosphatase (ALP), total bilirubin, 
nitric oxide (NO) markers, interleukin (IL-6) and tumor necrosis 
factor-alpha (TNF-α). Each liver was dissected out, washed in 
normal cold saline, and dissected into two parts. One part was 
embedded in 10% neutral buffered formalin for the 
histopathological and the part for immune-histochemical 
examinations. 
Biochemical analysis 
The activities of AST and ALT were assayed by the method of[20], 
while serum activity of ALP was determined according to the 
procedure of [21]. The colorimetric method of [22] was applied for 
the determination of serum contents total bilirubin. IL-6 was 
determined using Abcam’s Rat ELISA Kit (ab119548). Serum TNF-α 
was measured by ELISA. The VEGF was determined using an 
enzyme-linked immunosorbent assay (ELISA) kit. 
Histopathological examinations 
Liver tissues, preserved in neutral buffered formalin 10% solution, 
were processed to obtain Formalin Fixed Paraffin Embedded (FFBE) 
blocks. Changes were assessed in histopathological sections at 3-
micron and then stained with haematoxylin and eosin (H and E). 
Immuno-histochemical study 
Proliferating cell nuclear antigen (PCNA) 
Five-lm-thick neutral buffered formalin-fixed sections were 
deparaffinized in xylene, hydrated in a descending series of ethanol to 
phosphate-buffered saline (PBS; pH 7.5). Sections were prepared to 
quantify proliferating cell nuclear antigen (PCNA) and protein 
expression. The avidin-biotin complex immunoperoxidase staining 
system was used. Primary antibodies used were: monoclonal mouse 
anti-proliferating cell nuclear antigen (PCNA; clone PC 10; Dako 
Corporation, Carpentaria CA, Denmark). Tissue refreshment was 
performed using 3% H2O2for 30 min at 100 °C and washed in two 
changes of PBS. The primary antibodies were then marked with 
biotinylated goat anti-mouse IgG antibody for 35 min at room 
temperature, washed in two changes of PBS; then the sections were 
incubated with streptavidin-conjugated peroxidase for 35 min. After 
washing in PBS, the reaction was colored by exposing sections to 3,3-
diaminobenzidine (DAB) solution for 10 min, then washed in distilled 
water (2 changes) and counterstained with 1% methy1 green stain. After 
washing in tap water, the sections were dehydrated, cleared in xylene 
and mounted with Canada balsam. Control reaction was carried out by 
removing specific primary antibodies for PCNA.  
Caspase-3  
Immunohistochemical staining performed on 4-μm, formalin-fixed, 
paraffin-embedded sections using caspase 3 antibodies at 1:50 
dilution. Antigen retrieval was performed in all cases by steam 
heating the slides in a 1-mmol/l solution of EDTA (pH 8.0) for 30 
min. After blocking of endogenous biotin, staining was performed 
using an automated immunostainer (DAKO) followed by detection 
by using a streptavidin-biotin detection system. Positive and 
negative control sections used for each assay. 
Statistical analysis  
Data were coded and entered using the statistical package for the 
Social Sciences (SPSS) version 25 (IBM Corp., Armonk, NY, USA). 
Data were summarized using mean and standard error of the mean 
(SEM) for quantitative variables. Comparisons between groups were 
done using analysis of variance (ANOVA) with multiple comparisons 
post hoc test for comparison between every two groups [23].  
RESULTS  
Impact of AgNPs on serum liver enzymes and total bilirubin 
It was evident from the table 1, fig. 1, and fig. 2 that DEN/CCl4 
control group showed an elevated level of all hepatic parameters i.e. 
 
AST, ALP, ALT and serum total bilirubin with respect to a normal 
control group. DENA/CCl4 induced hepatic cancer group when 
 




ALT (ng/ml) 27.67±0.56 
AST (ng/ml) 38.5±1.36 
ALP (mg/ml) 57.5±1.12 
Total bilirubin(mg/ml) 21.33±1.52 
Values are presented as mean±SEM*: statistically significant compared to corresponding value NC group (P<0.05)
compared to the corresponding value in SC group (P<0.05) $: statistically significant compared to 
 
Impact of AgNPs on serum Il-6, TNF-αand VEGF levels 
Table 2 and fig. 3 speaks about the proinflammatory cytokines (TNF
α, IL-6) and the raised level of TNF-α and IL-6 in DEN/CCl4
rats was significantly decreased by AgNPs administration manner 
 
Table 2: Effects of AgNPs
Groups 
parameters 
Normal control (NC) 
IL-6 (pg/ml) 96±1.93 
TNF-alpha (pg/ml) 96±1.93 
VEGF (pg/ml) 53.67±4.4 
Values are presented as mean±SEM*: statistically significant compared to corresponding value NC group (P<0.05) #: statistical
compared to the corresponding value in SC group (P<0.05) $: statistically significant compared to corresponding value in HCC group (P<0.05).
 
Table 3: Effects of AgNPs on
Groups  
parameters 
Normal control (NC) 
NO µmol/l 52.67±0.92 
Values are presented as mean±SEM*: statistically significant compared to corresponding value NC group (P<0.05) #: statistical
compared to the corresponding value in SC group (P<0.05) $: statistically significant compared to 
 
Impact of AgNPs on serum nitric oxide (NO) levels
DENA/CCl4 induced rats affirmed the enhanced level of NO, when 
contrasted with normal control rats. AgNPs treatment revealed the 
dose-dependent lessening in NO, which confirms the antioxidant 
property of treatment (table 3 and fig. 4). 
Impact of AgNPs on DENA/CCl4
histopathological changes 
Histopathological examination of liver sections of a normal control 
group (Group I) stained with H and E showed normal hepatic
configuration. The liver cells are arranged in the form of cords 
 
Fig.
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treated with AgNPs significantly declined the levels of all hepatic 
serum markers. 
activities and total bilirubin levels in rats
 Solvent control (SC) HCC group HCC+AgNPs group (300 mg/kg)
28.33±1.17 239.67±9.64 *# 64±5.3 *#$
42.67±0.92 265±7.96 *# 86.33±2.01 *#$
68±0.73 263.33±5.58 *# 89.67±3.66 *#$
32±1.1 206.67±9.19 *# 71±3.71 *#$




toward the finish of the experiment. In other word
the same result as that of TNF α and IL
hepatocarcinogenesis demonstrated the elevated level of VEGF with 
respect to a normal control rats.
 on serum Il-6, TNF-αand VEGF levels in rats
Solvent control (SC) HCC group 
107.67±2.49 364.33±14.77 *# 
110.33±3.66 474.33±22.85 *# 
63.67±2.84 432±28.59 *# 
 nitric oxide (NO) levels in rats 
Solvent control (SC) HCC group 
54.67±0.56 108.83±3.56 *# 




radiating from the central vein to the periphery (
sections of Groups II, which was administered with olive oil without 
the induction of HCC, also showed the features of normal liver
indicating that there is no adverse effect of the olive oil on the liver 
(Fig.6). In contrast, the sections of the liver from HCC control group 
(Group III) showed a loss of lobular architecture. It also evidenced 
the features of necrosis, apoptosis, and d
7, 8). It also revealed the dilatation and proliferation of bile duct and 
fatty degeneration. DENA/CCl4
(300 mg/kg body weight) showed marked improvements with 
almost restored lobular architecture and reduction in fatty 
degeneration (fig. 9). 
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Fig. 3: Effects of AgNPs on serum Il
Fig.
 
Fig. 5: (Control): high power view showing average portal tract (black arrow) with average portal vein (PV), average bile ducts (b
arrow), average hepatic artery (red arrow), and average hepatocytes in peri
shows liver showing average portal tract (black arrow) with average portal vein (PV) and average bile ducts (BD), average cen
(blue arrow) and average hepatocytes (yellow arrow) (HandE X 200). Fig. 7: (HCC group) bile duct proliferatio
arrow) more apoptotic nucleus ((black arrow) and show necrotic area (yellow arrows) (HandE X 400). Fig. 8: (HCC group) liver 
showed diffused macrosteatosis (black arrow) and apoptotic nuclei (yellow arrows) (HandE X 400). Fig.
power view showing marked improvement with portal tract with dilated congested portal vein (PV), average bile ducts (BD), and
hepatocytes showing mild micro
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 2: Effects of AgNPs on total bilirubin levels in rats 
 
 
-6, TNF-αand VEGF levels in rats 
 
 4: Effects of AgNPs on nitric oxide (NO) levels in rats 
-portal area (yellow arrows) (HandE X 400). Fig. 6: 
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Proliferating cell nuclear antigen (PCNA) immune staining reaction 
was confined to the nuclei. The reaction product was present in 
different patterns from a faint to strong densely stained nuclear 
granular reaction filling the whole nucleus. Only moderately to 
strongly stained nuclei were considered as positive. Sections for the 
control reaction gave a negative PCNA stain. In the normal control 
 
Fig. 10: (control and SC groups): liver section of normal control rat showing few PCNA positive hepatocytes nuclei (arrows), (X 400). 
Fig. (11and12): (HCC group): Liver section post DEN/CCL
(X 400). Fig. 13: (HCC+AgNPs group) Photomicrographs of hepatic sections revealed mild expressions of PCNA cells o
Immunohistochemistry was used for the detection of caspase
positive cells in liver samples. Immunohistochemical
sections of the normal control group showed classical 
immunoreactivity to cleaved caspase-3 (fig. 14). In contrast, the liver 
sections of the hepatic cancer-induced group (HCC group) showed 
increased immunoreactivity to cleaved caspase
 
Fig. 14: hepatic section of control and solvent control rats showing low expressions of caspase
brownish color, (arrow), (HandE X 400). Fig. (15): hepatic tissues of HCC rats showing wide spread of positive immune reactiv
caspase-3 (arrows), (HandE X 400). Fig.(16): Photomicrographs of hepatic sections of HCC rats treated wit
expression for cas
DISCUSSION  
Hepatocarcinogenesis is a multistage process with the intervention 
of multiple risk factors such as chemical exposure
DENA/CCl4-chemical model of HCC in animals, a multi
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liver sections, there were a few numbers of PCNA positive nuclei 
10). Examination of liver sections in group II after receiving olive oil 
injection showed few numbers of PCNA positive nuclei the same as 
the normal group. Examination of liver sections of HCC group 
showed more predicted number of PCNA positive nucle
intensity of immunostaining (fig. 11
administration there was an obvious decrease in the number of 
PCNA positive nuclei as compared with HCC group (fig. 13).
4 injection showing increase in the number of PCNA positive nuclei (arrows), 
(arrows), (X 400) 
 
-3-
 analysis of liver 
-3 compared to the 
normal control group (fig. 15
toward hepatocytes in the liver sections of the group treated with 
AgNPs was analyzed to compare the efficacy of the target of green 
biosynthesized of AgNPs by the seeds of Nigella sativa. Many 
hepatocytes showed decreased immunoreactivity to cleaved 
caspase-3 (fig. 16). 
-3 immune reactive cells a
pase-3, (arrows), (HandE X 400) 
 
 [24]. In the 
-step of 
hepatic carcinogenesis is achieved, where the DENA
is followed by the CCl4-promotion stage. DENA is an N
alkylating agent which is quickly metabolized and collected in the 
liver, finishing in the formation of numerous DNA adducts such as 
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promotion with CCl4 is the hepatic cirrhosis, carcinogenesis, and HCC 
simulating the human histopathological and clinical pictures [6]. The 
present study was an endeavor to the silver nanoparticles of a plant 
extract with a result to control the development of hepatic cancer in 
rats. 
In the present study, DENA/CCl4-induced oxidative stress can induce 
liver tissue damage and hence modify its function. Zhao et al. 
recorded that the AST, ALT, ALP,and total bilirubin serum levels are 
indicators for hepatic function, their increase is correlated with the 
hepatic injury. DEN hepatic injury is related to the disturbance in 
hepatocytes membrane instability and metabolism resulting in 
alterations of the serum levels of these enzymes. Al-Rejaie et al. 
mentioned that increase of ALT and AST levels are specific to 
hepatocellular disturbance [41]. ALP is a liver function enzyme that 
related to the membrane lipid in canalicular ducts. ALP increase in 
serum reflects the biliary flow disturbance. So, the extra or intra-
hepatic interference with the bile flow leads to the elevation of ALP 
serum levels. Also, various studies documented the increase in ALT 
and AST levels may be due to the spillage of these cytosolic enzymes 
and, moving towards the circulatory system occurred because of 
hepatic destruction after DEN introduction. This is beginning of 
hepatocellular destruction because of the hypofunction of liver and 
interruption in the biosynthesis of these serum markers enzymes, 
with changing the penetrability of the liver cell membrane [26]. 
The current result revealed a significantly reduction in the levels of 
these enzymes after AgNPs administration because of changing the 
permeability and integrity of liver membrane. Such a result runs in 
full agreement with that of [27]. 
Bilirubin is produced as a metabolic product of haemoglobin, which 
involves in conjugation with glucuronic acid in hepatocytes. 
Estimation of serum bilirubin imparts a main role in estimation of 
hepatic capacity, and any irregular increment in the levels of serum 
bilirubin demonstrates hepatobiliary illnesses and inflammation of 
liver function[28]. Also, Rajkapoor et al. reported that a significant 
increase in the level of serum bilirubin might be due to the mass 
hindrance of the conjugation response and release of unconjugated 
bilirubin from damaged hepatocytes [29]. Treatment with AgNPs 
decreased the content of serum bilirubin and involves in the 
regeneration of normal activity of liver. 
IL-6 is an immunoregulatory cytokines produced by cancer cells and 
associated macrophages, its high serum level is associated with 
specific immune and metabolic alterations that lead to cancer 
cachexia, one of the main causes of death in cancer. During 
inflammation, IL-6 regulates the response of certain liver-specific 
transcription factors [30]. In addition, IL-6 is a positive regulator of 
growth and play a role in the proliferation, differentiation, and 
apoptosis of myeloid cells [31]. It inhibits apoptosis in cancer cells 
and stimulates angiogenesis. It regulates growth in solid tumors 
through paracrine and autocrine actions Also, IL-6 is associated with 
the stage of tumor and survival. IL-6 acts as a mutagenic, motogenic, 
morphogenic, proneoangiogenic, and hepatocyte growth factor in 
HCC and thus plays a role in HCC carcinogenesis. Jin et al. reported 
that IL-6 is produced by Kupffer cells and stimulates compensatory 
regeneration which may be important in DENA-induced 
hepatocarcinogenesis [32]. IL-6 is considered to be an 
hepatoprotective cytokine, although it has also been shown that 
persistent high levels of IL-6 cause liver damage. 
HCC is likely to produce angiogenic factors. VEGF is considered the 
strongest stimulator for angiogenesis, and plays an important role in 
the course of carcinogenesis and metastasis [33]. VEGF is 
significantly elevated in HCC as HCC is a highly vascular tumor, and 
tumor angiogenesis is critical for both its growth and metastasis 
[35]. As an inflammatory, apoptotic, and angiogenic cytokine, TNF-α 
has various important roles in HCC pathogenesis. It leads to 
superoxide formation, with either activation of the caspase-8, 
and/or induction of necroptosis. The necroptosis cell death is a 
consequence of caspase inactivity with the engagement of death 
receptors mainly TNF receptor-1 (TNFR1). Moreover, the 
upregulated expression of VEGF/VEGF receptors and IL-8 are 
evidenced after TNF-α production [36]. Recently, Aboubakr et al. 
reported that circulating pro-inflammatory cytokines, such as TNF-α 
and IL-6 which triggers hepatic injury, were increased at least in 
part by a free-radical-mediated apoptotic mechanism [37]. 
In the current study, the DENA/CCl4-challenging showed increases in 
the NO. In HCC, poor prognosis is associated with upregulated 
angiogenic factor and excessive tumor vasculature. In dynamic 
paracrine and autocrine manners, the hepatic stromal, tumor and 
stellate cells are considering major sources of these angiogenic 
factors [38]. The higher hepatic NO production is playing very 
important roles in neoplastic transformation and progression 
through DNA damage. Moreover, the hepatic cancer cells with 
multidrug resistance protein-1 (MDR1) phenotype display marked 
inducible nitric oxide synthase expression and NO levels. In this 
investigation, we observed that AgNPs decreased NO levels in 
DENA/CCl4 induced liver cancer. These manifested that AgNPs can 
lessen reactive oxygen species and diminishing oxidative destruction 
to the hepatic tissues other than enhancing the action of enzymatic 
antioxidant parameters. 
In this study, the histological study of the livers of those rats exposed 
to DENA/CCl4 showed the existence of several histological changes, 
including areas of necrosis, apoptotic cells which are extremely rare 
in normal livers which might be due to the excessive free radicals 
generation during DENA/CCl4 administration. Such findings strongly 
suggest the ability of DENA to initiate hepatocarcinogenesis with the 
interactive effect of CCl4. The same observation was documented by 
many authors [39, 40]. The histological features suggested that 
AgNPs are effective in reducing DEN-induced hepatocarcinogenesis. 
Immunohistochemistry was used for the detection of PCNA and 
caspase-3-positive cells in liver samples. PCNA is a cofactor of DNA 
polymerase-delta and an index of the rate of cell turnover or cell 
proliferation [41]. PCNA is involved in protein–protein interactions 
[42] and in the DNA damage tolerance pathway known as post-
replication repair [43]. The present work demonstrated that PCNA 
immuno-histochemically as potential molecular biomarkers. These 
investigations were done to improve our understanding of 
histopathological changes. It was suggested that cancer associated 
with elevated levels of PCNA whose levels were used as a predictive 
marker in various cases [44]. 
Caspases are aspartate-specific cysteine proteases and members of 
the interleukin-1 (IL-1) β-converting enzyme family. These enzymes 
are produced in inactive forms and are activated in a protease 
cascade. Caspases are often classified into initiators (caspase-1, −2, 
−4, −5, −8, −9, −10, −11, −12) and effector caspases (caspase-3, −6, 
−7). The latter ones, with caspase-3 being considered the most 
important member, are responsible for the execution of apoptosis or 
programmed cell death [45]. Apoptosis is a form of programmed cell 
death characterized by DNA fragmentation, cytoplasmic shrinkage, 
membrane changes, and cell death without lysis or damage to the 
neighboring cells. Apoptosis is important during development, for 
normal tissue homeostasis, and as a protective mechanism to get rid 
of damaged cells owing to diseases or toxins. On the contrary, 
inappropriate apoptosis has been implicated in the development of 
cancer, neurodegenerative disorders, and autoimmune diseases 
[46]. Caspases take part in both the intrinsic and extrinsic apoptosis 
pathways. However, caspase-3, also known as the executioner 
caspase, is responsible for the morphological changes such as 
chromatin condensation, DNA breakdown and laddering, and 
breakdown of membrane proteins [47]. 
Many attempts have been made to use AgNPs as an anticancer agent 
and they have all turned up to be positive [48]. The size reduction of 
nanoparticles plays an important role in improving their bio-
availability and compatibility for therapeutical applications in 
diseases like cancer. Developing more effective and less toxic 
anticancer agents, including natural products, are necessary to 
prevent or delay the process from hepatocarcinogenesis [49]. AgNPs 
have been recorded to extend chemopreventive activities by 
controlling the tumor in vivo [50] 
CONCLUSION 
In conclusion, based on the present study results, we suggest the 
therapeutic effect of AgNPs synthesized by the green method using 
Nigella sativa against diethylnitrosamine and carbon tetrachloride-
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induced hepatocellular carcinoma in rats. AgNPs would exert a 
chemopreventive effect by restoring the activities of hepatic marker 
enzymes and lessen reactive oxygen species and diminishing oxidative 
destruction to the hepatic tissues during hepatocarcinogenesis. 
FUNDING 
Nil 
AUTHORS CONTRIBUTIONS  
All the authors have contributed equally. 
CONFLICT OF INTERESTS  
Declared none 
REFERENCES 
1. Zhu RX, Seto WK, Lai CL, Yuen MF. Epidemiology of hepatocellular 
carcinoma in the asia-pacific region. Gut Liver 2016;10:332. 
2. Mishra S, Hora S, Shukla V, Das M, Kharkwal H, Katare DP. 
Sustained release tablets of sorafenib-silibinin combinations 
for the treatment of hepatocellular carcinoma. Int J Appl Pharm 
2018;10:117-24. 
3. Ding Y, Peng Z, Ding L, Peng Y. Baishouwu extract suppresses 
the development of hepatocellular carcinoma via 
TLR4/MyD88/NF-kB. Pathway 2019;10:1-14.  
4. Ramakrishnan G, Augustine T, Jagan S, Vinodhkumar R, Devaki 
T. Effect of silymarin on N-nitrosodiethylamine induced 
hepatocarcinogenesis in rats. Exp Oncol 2007;29:39-44. 
5. Wang F, Qu W, Li Y, Liu H, Li B, Qi J, et al. Diethyl nitrosamine 
alone was not recommended for primary hepacellular 
carcinoma model in rats. Int J Clin Exp Pathol 2016;9:10346-50. 
6. Uehara T, Ainslie GR, Kutanzi K, Pogribny IP, Muskhelishvili L, 
Izawa T, et al. Molecular mechanisms of fibrosis-associated 
promotion of liver carcinogenesis. Toxicol Sci 2013;132:53-63.  
7. Muto J, Shirabe K, Sugimachi K, Maehara Y. Review of 
angiogenesis in hepatocellular carcinoma: Angiogenesis in 
hepatocellular carcinoma. Hepatol Res 2015;45:1–9. 
8. Satyavani K, Gurudeeban S, Balasubramanian TR. Biomedical 
potential of silver nanoparticles synthesized from calli cells of 
Citrullus colocynthis(L.) Schrad. J Nanobiotechnol 2011;9:43.  
9. Reshi MS, Uthra C, Yadav D, Sharma S, Singh A, Sharma A, et al. 
Silver nanoparticles protect acetaminophen-induced acute 
hepat otoxicity: a biochemical and histopathological approach. 
Regulatory Toxicol Pharmacol 2017;90:364. 
10. Priyadarshni KC, Mahalingam PU. Antimicrobal and anticancer 
activity of silver nanoparticles from edible mushroom: a 
review. Asian J Pharm Clin Res 2017;10:37-40.  
11. Gurunathan S, Lee KJ, Kalishwaralal K, Sheikpranbabu S, 
Vaidyanathan R, Eom SH. Antiangiogenic properties of silver 
nanoparticles. Biomaterials 2009;30:6341–5. 
12. Kalishwaralal K, Banumathi E, Pandian SRK, Deepak V, 
Muniyandi J, Eom SH, et al. Silver nanoparticles inhibit VEGF 
induced cell proliferation and migration in bovine retinal 
endothelial cells. Colloids Surf B Biointerfaces 2009;73:51–7. 
13. Zhu B, Lin N, Zhang M, Zhu Y, Cheng H, Chen S, et al. Activated 
hepatic stellate cells promote angiogenesis via interleukin-8 in 
hepatocellular carcinoma. J Transl Med 2015;13:365. 
14. Hader A, Aqel M, Hasan Z. Hypoglycemic effects of the volatile 
oil of Nigella sativa seeds. Pharmaceutical Biol 1993;31:96-100. 
15. Kalus U, Pruss A, Bystron J, Jurecka M, Smekalova A, Lichius JJ, et 
al. Effect of Nigella sativa (black seed) on subjective feeling in 
patients with allergic diseases. Phytother Res 2003;17:1209-14.  
16. Bourgou S, Pichette A, Marzouk B, Legault J. Antioxidant, anti-
inflammatory, anticancer and antibacterial activities of extracts 
from Nigella sativa (Black cumin) plant parts. J Food Biochem 
2012;36:539-46. 
17. Motawi TK, El-Boghdady NA, El-Sayed AM, Helmy HS. 
Comparative study of the effects of PE gylated interferon-α2a 
versus 5-fluorouracil on cancer stem cells in a rat model of 
hepatocellular carcinoma. Tumor Biol 2016;37:1617–25. 
18. Sarkar A, Basak R, Bishayee A, Basak J, Chatterjee M. B-
Carotene inhibits rat liver chromosomal aberrations and DNA 
chain break after a single injection of diethylnitrosamine. Br J 
Cancer 1997;76:855–61.  
19. Dakshayani KB, Subramanian P, Manivasagam T, Mohamed EM, 
Manoharan S. Melatonin modulates the oxidant–antioxidant 
imbalance during N-nitrosodiethylamine induced 
hepatocarcinogenesis in rats. J Pharm Pharm Sci 2005;8:316-21. 
20. Bergmeyer HU, Scheibe P, Wahlefeld AW. Optimization of 
methods for aspartate aminotransferase and alanine 
aminotransferase. Clin Chem 1978:24:58–73. 
21. Belfield A, Goldberg D. Colorimetric determination of alkaline 
phosphatase activity. Enzym 1971;12:561-6.  
22. Walter M, Gerade H. A colorimetric method for determination 
of bilirubin in serum and plasma. Micro Chem J 1970;15:231–6. 
23. Chan YH. Biostatistics102: quantitative data–parametric and 
non-parametric tests. Singapore Med J 2003;44:391-6. 
24. Singh A, Dar MY, Joshi B, Sharma B, Shrivastava S, Shukla S. 
Phytofabrication of silver nanoparticles: novel drug to 
overcome hepatocellular ailments. Tox Rep 2018;5:333-42. 
25. Al-Rejaie SS, Aleisa AM, Al-Yahya AA. Progression of 
diethylnitrosamine-induced hepatic carcinogenesis in carnitine-
depleted rats. World J Gastroenterol 2009;15:1373-80. 
26. Erejuwa OO, Sulaiman SA, Wahab MS, Sirajudeen KNS, Salleh 
MS, Gurtu S. Hepatoprotective effect of tualang honey 
supplementation in streptozotocin-induced diabetic rats. Int J 
Appl Res Nat Prod 2011;463:39–44. 
27. Singha D, Singhb M, Yadava E, Fallsc N, Dangid DS, Kumarc V, et 
al. Attenuation of diethylnitrosamine (DEN)–Induced hepatic 
cancer in experimental model of wistar rats by Carissa 
carandas embedded silver nanoparticles. Biomed 
Pharmacother 2018;108:757–65. 
28. Pal S, Bhattacharjee A, Mukherjee S, Bhattacharya K, Mukherjee 
S, Khowala S. Effect of alocasia indica tuber extract on reducing 
hepatotoxicity and liver apoptosis in alcohol intoxicated rats. 
Biomed Res Int 2014:10. 
https://doi.org/10.1155/2014/349074 
29. Rajkapoor B, Jayakar B, Murugesh N, Sakthiskaran D. 
Chemoprevention and cytotoxic effect of Bauhinia variegata 
against N-nitrosodiethylamine induced liver tumors and 
human cancer cell lines. J Ethnopharmacol 2006;104:407-9. 
30. Porta C, De Amici M, Quaglini S, Paglino C, Tagliani F, 
Boncimino A, et al. Circulating interleukin-6 as a tumor marker 
for hepatocellular carcinoma. Ann Oncol 2008;19:353-8. 
31. Łukaszewicz M, Mroczko B, Szmitkowski M. Clinical 
significance of interleukin-6 (IL-6) as a prognostic factor of 
cancer disease. Pol Arch Med Wewn 2007;117:247-51. 
32. Jin X, Zimmers TA, Perez EA, Pierce RH, Zhang Z, Koniaris LG. 
Paradoxical effects of short and long-term interleukin-6 exposure 
on liver injury and repair. Hepatology 2006;43:474–84. 
33. El-Houseini ME, Mohammed MS, Elshemey WM. Enhanced 
detection of hepatocellular carcinoma. Cancer Control 
2005;12:248–53. 
34. Tan A, Kim R, El-Gazzaz G. Serum vascular endothelial growth 
factor level in patients with hepatocellular carcinoma 
undergoing liver transplantation: experience of a single 
Western center. Int J Organ Transplant Med 2012;3:42–51. 
35. Darvesh AS, Aggarwal BB, Bishayee A. Curcumin and liver 
cancer: a review. Curr Pharm Biotechnol 2012;13:218–28. 
36. Talaat RM, Adel S, Salem TA, Nasr MI. Correlation between 
angiogenic/inflammatory mediators in Wister rat model of 
liver dysplasia. J Immunoassay Immunochem 2016;37:472–84. 
37. Aboubakr EM, Taye A, Aly OM, Gamal-Eldeen AM, El-Moselhy MA. 
Enhanced anticancer effect of combretastatin A-4 phosphate when 
combined with vincristine in the treatment of hepatocellular 
carcinoma. Biomed Pharmacother 2017;89:36-46. 
38. Otto W, Sierdzinski J, Krol M, Wolinska E, Feliksbrot 
Bratosiewicz M, Wilkowojska U. Thvalue of tumor angiogenesis 
activity for stratification of HCC patients. Int J Clin Exp Med 
2017;10:4200–13. 
39. Barretto OC, Zyngier SB. Acquired disturbance of erythrocyte 
glutathione reductase in experimental tumors. J Cancer Res 
Clin Oncol 1984;108:252–3. 
40. Jim JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS. Twenty-
eight-day inhalation toxicity study of silver nanoparticles in 
sprague dawley rats. Inhal Toxicol 2007;19:857–71. 
41. Freudenthal BD, Ramaswamy S, Hingorani MM, Washington 
MT. Structure of a mutant form of proliferating cell nuclear 
Hassen et al. 
Int J Pharm Pharm Sci, Vol 12, Issue 9, 1-8 
8 
 
antigen that blocks translation DNA synthesis. Biochemistry 
2008;47:13354–61. 
42. Maga G, Hubscher U. Proliferating cell nuclear antigen (PCNA): 
a dancer with many partners. J Cell Sci 2003;116:3051–60. 
43. Lehmann AR, Fuchs RP. Gaps and forks in DNA replication: 
rediscovering old models. DNA Repair 2006;5:1495–8. 
44. Czyzewska J, Guzinska Ustymowicz K, Lebelt A, Zalewski B, 
Kemona A. Evaluation of proliferating markers Ki-67, PCNA in 
gastric cancers. Rocz Akad Med Bialymst 2004;49:64–6. 
45. Li J, Yuan J. Caspases in apoptosis and beyond. Oncogene 
2008;27:6194–206. 
46. Jones JR, Kong L, Hanna MGIV, Hoffman B, Krencik R, Bradley R, 
et al. Mutation in GFAP disrupt the distribution and function of 
organelle in humanastrocytes. Cell Report 2018;25:947–58. 
47. D’Amelio M, Cavallucci V, Cecconi F. Neuronal caspase-3 
signaling: not only cell death. Cell Death Differ 2010;17:1104–
14. 
48. Vaidyanathan R, Kalishwaralal K, Gopalram S, Gurunathan S. 
Nano silver-the burgeoing therapeutic molecule and its green 
synthesis. Biotechnol Adv 2009;27:924-37. 
49. Tabone M, Pellicano R. Prevention of intrahepatic hepato-
carcinoma recurrence in patients with viral cirrhosis: two 
potential options. Minerva Gastroenterol Dietol 
2006;52:47-52. 
50. Antony JJ, Sithika MAA, Joseph TA, Suriyakalaa U, Sankarganesh 
A, Siva D, et al. In vivo antitumor activity of biosynthesized 
silver nanoparticles using ficus religiosa as a nanofactory in 
DAL induced mice model. Colloids Surf B 2013;108:185-90.
 
